Metabolomics discloses donor liver biomarkers associated with early allograft dysfunction

Journal of Hepatology

Volumn 61, Issue 3, 2014, Pages 564-574

  Cortes, Miriam ^a   Pareja, Eugenia ^a   García Cañaveras, Juan C ^a,b   Donato, M Teresa ^a,b   Montero, Sandra ^a   Mir, Jose ^a   Castell, José V ^a,b   Lahoz, Agustín ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b FIS   (Spain)

Author keywords

Lipidomics; Liver dysfunction; Liver transplant; Mass spectrometry; Primary non function

Indexed keywords

ALANINE AMINOTRANSFERASE; BILE ACID; BILIRUBIN; BIOLOGICAL MARKER; HISTIDINE; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHOLIPID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID; SPHINGOMYELIN;

ACCURACY; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; COHORT ANALYSIS; EARLY ALLOGRAFT DYSFUNCTION; FEMALE; HUMAN; HUMAN TISSUE; INTERNATIONAL NORMALIZED RATIO; LIPID HOMEOSTASIS; LIQUID CHROMATOGRAPHY; LIVER BIOPSY; LIVER GRAFT; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; METABOLOMICS; ORGAN DONOR; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; SENSITIVITY AND SPECIFICITY; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ALLOGRAFT; BIOPSY; DONOR; EVALUATION STUDY; GRAFT REJECTION; LIVER; LIVER TRANSPLANTATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; RISK FACTOR;

ALLOGRAFTS; BILE ACIDS AND SALTS; BIOLOGICAL MARKERS; BIOPSY; FEMALE; GRAFT REJECTION; HISTIDINE; HUMANS; LIVER; LIVER TRANSPLANTATION; LYSOPHOSPHOLIPIDS; MALE; METABOLOMICS; MIDDLE AGED; PHOSPHOLIPIDS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SPHINGOMYELINS; TISSUE DONORS;

EID: 84906318371     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.04.023     Document Type: Article

References (53)

1. J.P. Duffy, D.G. Farmer, and R.W. Busuttil A quarter century of liver transplantation at UCLA Clin Transpl 2007 165 170
2. R. Adam, V. Karam, V. Delvart, J. O'Grady, D. Mirza, and J. Klempnauer et al. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR) J Hepatol 57 2005 675 688
3. N.R. Barshes, I.B. Horwitz, L. Franzini, J.M. Vierling, and J.A. Goss Waitlist mortality decreases with increased use of extended criteria donor liver grafts at adult liver transplant centers Am J Transplant 7 2007 1265 1270
4. L. Makowka, R.D. Gordon, S. Todo, N. Ohkohchi, J.W. Marsh, and A.G. Tzakis et al. Analysis of donor criteria for the prediction of outcome in clinical liver transplantation Transplant Proc 19 1987 2378 2382
5. E. Mor, G.B. Klintmalm, J.F. Gibbs, I. Watemberg, R.M. Goldstein, and B.S. Husberg The use of marginal donors for liver transplantation, a retrospective study of 365 liver donors Transplantation 53 1992 383 386
6. S.M. Strasberg, T.K. Howard, E.P. Molmenti, and M. Hertl Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation Hepatology 20 1994 829 838
7. J. Briceno, and R. Ciria Early graft dysfunction after liver transplantation Transplant Proc 42 2010 631 633
8. P. Salvalaggio, R.C. Afonso, G. Felga, and B.H. Ferraz-Neto A proposal to grade the severity of early allograft dysfunction after liver transplantation Einstein 11 2013 23 31
9. R.J. Ploeg, A.M. D'Alessandro, S.J. Knechtle, M.D. Stegall, J.D. Pirsch, and R.M. Hoffmann et al. Risk factors for primary dysfunction after liver transplantation-a multivariate analysis Transplantation 55 1993 807 813
10. K.M. Olthoff, L. Kulik, B. Samstein, M. Kaminski, M. Abecassis, and J. Emond et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors Liver Transpl 16 2010 943 949
11. H. Vilca Melendez, M. Rela, G. Murphy, and N. Heaton Assessment of graft function before liver transplantation: quest for the lost ark? Transplantation 70 2000 560 565
12. J.K. Nicholson, J.C. Lindon, and E. Holmes 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data Xenobiotica 29 1999 1181 1189
13. C.U. Niemann, and N.J. Serkova Biochemical mechanisms of nephrotoxicity: application for metabolomics Expert Opin Drug Metab Toxicol 3 2007 527 544
14. J.C. Garcia-Canaveras, M.T. Donato, J.V. Castell, and A. Lahoz A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations J Proteome Res 10 2011 4825 4834
15. R. Chen, G.I. Mias, J. Li-Pook-Than, L. Jiang, H.Y. Lam, and E. Miriami et al. Personal omics profiling reveals dynamic molecular and medical phenotypes Cell 148 2012 1293 1307
16. M.M. Sarwal Deconvoluting the 'omics' for organ transplantation Curr Opin Organ Transplant 14 2009 544 551
17. D.S. Wishart Metabolomics: the principles and potential applications to transplantation Am J Transplant 5 2005 2814 2820
18. O. Hrydziuszko, M.A. Silva, M.T. Perera, D.A. Richards, N. Murphy, and D. Mirza et al. Application of metabolomics to investigate the process of human orthotopic liver transplantation: a proof-of-principle study Omics 14 2010 143 150
19. N.J. Serkova, Y. Zhang, J.L. Coatney, L. Hunter, M.E. Wachs, and C.U. Niemann et al. Early detection of graft failure using the blood metabolic profile of a liver recipient Transplantation 83 2007 517 521
20. C. Legido-Quigley, L. McDermott, H. Vilca-Melendez, G.M. Murphy, N. Heaton, and J.C. Lindon et al. Bile UPLC-MS fingerprinting and bile acid fluxes during human liver transplantation Electrophoresis 32 2011 2063 2070
21. United Network for Organ Sharing Liver Disease Severity Score C. www.UNOS.org.
22. H. He, and E.A. Garcia Learning from imbalanced data IEEE Trans Knowl Data Eng 21 2009 1263 1284
23. T.E. Starzl, S. Iwatsuki, C.O. Esquivel, S. Todo, I. Kam, and S. Lynch et al. Refinements in the surgical technique of liver transplantation Semin Liver Dis 5 1985 349 356
24. A. Serralta, M.T. Donato, A. Martinez, E. Pareja, F. Orbis, and J.V. Castell et al. Influence of preservation solution on the isolation and culture of human hepatocytes from liver grafts Cell Transplant 14 2005 837 843
25. W.A. Marsman, R.H. Wiesner, L. Rodriguez, K.P. Batts, M.K. Porayko, and J.E. Hay et al. Use of fatty donor liver is associated with diminished early patient and graft survival Transplantation 62 1996 1246 1251
26. E. Levesque, E. Hoti, M. Khalfallah, C. Salloum, and L. Ricca et al. Impact of reversible cardiac arrest in the brain-dead organ donor on the outcome of adult liver transplantation Liver Transpl 17 2011 1159 1166
27. G. Quintas, N. Portillo, J.C. García-Cañaveras, J.V. Castell, A. Ferrer, and A. Lahoz Chemometric approaches to improve PLSDA model outcome for predicting human non-alcoholic fatty liver disease using UPLC-MS as a metabolic profiling tool Metabolomics. 8 1 2012 86 98
28. D.S. Wishart, C. Knox, A.C. Guo, R. Eisner, N. Young, and B. Gautam et al. HMDB: a knowledgebase for the human metabolome Nucleic Acids Res 37 2009 D603 D610
29. E. Fahy, M. Sud, D. Cotter, and S. Subramaniam LIPID MAPS online tools for lipid research Nucleic Acids Res 35 2007 W606 W612
30. R Core Team. R Foundation for Statistical Computing V, Austria. R: A language and environment for statistical computing. ISBN 3-900051-07-0, URL http://wwwR-projectorg/ 2012.
31. J. Xia, R. Mandal, I.V. Sinelnikov, D. Broadhurst, and D.S. Wishart MetaboAnalyst 2.0 - a comprehensive server for metabolomic data analysis Nucleic Acids Res 40 2012 W127 W133
32. J. Briceño, R. Ciria, M. de la Mata, S. Rufián, and P. López-Cillero Prediction of graft dysfunction based on extended criteria donors in the model for end-stage liver disease score era Transplantation 90 2010 530 539
33. D.E. Schaubel, M.K. Guidinger, S.W. Biggins, J.D. Kalbfleisch, E.A. Pomfret, and P. Sharma et al. Survival benefit-based deceased-donor liver allocation Am J Transplant 9 2009 970 981
34. D.E. Schaubel, C.S. Sima, N.P. Goodrich, S. Feng, and R.M. Merion The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality Am J Transplant 8 2008 419 425
35. P.R. Salvalaggio, G.E. Felga, R.C. Afonso, and B.H. Ferraz-Neto Early allograft dysfunction and liver transplant outcomes: a single center retrospective study Transplant Proc 44 2012 2449 2451
36. M. Cortes, E. Pareja, J.V. Castell, A. Moya, J. Mir, and A. Lahoz Exploring mass spectrometry suitability to examine human liver graft metabonomic profiles Transplant Proc 42 2010 2953 2958
37. F.X. Gonzalez, A. Rimola, L. Grande, M. Antolin, J.C. Garcia-Valdecasas, and J. Fuster et al. Predictive factors of early postoperative graft function in human liver transplantation Hepatology 20 1994 565 573
38. N. Tanaka, T. Matsubara, K.W. Krausz, A.D. Patterson, and F.J. Gonzalez Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis Hepatology 56 2012 118 129
39. P. Puri, M.M. Wiest, O. Cheung, F. Mirshahi, C. Sargeant, and H.K. Min et al. The plasma lipidomic signature of nonalcoholic steatohepatitis Hepatology 50 2009 1827 1838
40. A.S. Arora, B.J. Jones, T.C. Patel, S.F. Bronk, and G.J. Gores Ceramide induces hepatocyte cell death through disruption of mitochondrial function in the rat Hepatology 25 1997 958 963
41. K. Kakisaka, S.C. Cazanave, C.D. Fingas, M.E. Guicciardi, S.F. Bronk, and N.W. Werneburg et al. Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis Am J Physiol Gastrointest Liver Physiol 302 2012 G77 G84
42. M.S. Han, S.Y. Park, K. Shinzawa, S. Kim, K.W. Chung, and J.H. Lee et al. Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes J Lipid Res 49 2008 84 97
43. A. Navarro-Sabate, C. Peralta, M.N. Calvo, A. Manzano, M. Massip-Salcedo, and J. Rosello-Catafau et al. Mediators of rat ischemic hepatic preconditioning after cold preservation identified by microarray analysis Liver Transpl 12 2006 1615 1625
44. A. Raza, G. Dikdan, K.K. Desai, A. Shareef, H. Fernandes, and V. Aris et al. Global gene expression profiles of ischemic preconditioning in deceased donor liver transplantation Liver Transpl 16 2010 588 599
45. P.B. Hylemon, H. Zhou, W.M. Pandak, S. Ren, G. Gil, and P. Dent Bile acids as regulatory molecules J Lipid Res 50 2009 1509 1520
46. H. Vilca Melendez, M. Rela, K.D. Setchell, G.M. Murphy, and N.D. Heaton Bile acids analysis: a tool to assess graft function in human liver transplantation Transpl Int 17 2004 286 292
47. M.S. Hedaya, W.M. El Moghazy, Y. Yasutomo, T. Kiyoshi, T. Kaido, and H. Egawa et al. Is biliary bile acid a good predictor for acute cellular rejection in living donor liver transplantation? Hepatobiliary Pancreat Dis Int 8 2009 474 478
48. L. Fouassier, M. Beaussier, E. Schiffer, C. Rey, V. Barbu, and M. Mergey et al. Hypoxia-induced changes in the expression of rat hepatobiliary transporter genes Am J Physiol Gastrointest Liver Physiol 293 2007 G25 G35
49. V. Defamie, R. Cursio, K. Le Brigand, C. Moreilhon, M.C. Saint-Paul, and M. Laurens et al. Gene expression profiling of human liver transplants identifies an early transcriptional signature associated with initial poor graft function Am J Transplant 8 2008 1221 1236
50. A. Motoki, N. Adachi, K. Liu, H.K. Takahashi, M. Nishibori, and T. Yorozuya et al. Suppression of ischaemia-induced cytokine release by dimaprit and amelioration of liver injury in rats Basic Clin Pharmacol Toxicol 102 2008 394 398
51. H. Francis, F. Meng, E. Gaudio, and G. Alpini Histamine regulation of biliary proliferation J Hepatol 56 2012 1204 1206
52. J. Balog, L. Sasi-Szabo, J. Kinross, M.R. Lewis, L.J. Muirhead, and K. Veselkov et al. Intraoperative tissue identification using rapid evaporative ionization mass spectrometry Sci Transl Med 5 2013 194ra193
53. K.C. Schafer, J. Denes, K. Albrecht, T. Szaniszlo, J. Balog, and R. Skoumal et al. In vivo, in situ tissue analysis using rapid evaporative ionization mass spectrometry Angew Chem Int Ed Engl 48 2009 8240 8242